GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 221 filers reported holding GUARDANT HEALTH INC in Q2 2019. The put-call ratio across all filers is 1.22 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $308,908 | -17.2% | 10,422 | 0.0% | 0.52% | +25.9% |
| Q2 2023 | $373,108 | +70.0% | 10,422 | +11.3% | 0.41% | +52.4% |
| Q1 2023 | $219,469 | -89.7% | 9,363 | -44.8% | 0.27% | -68.0% |
| Q3 2021 | $2,122,000 | -19.4% | 16,975 | -19.9% | 0.84% | -1.1% |
| Q2 2021 | $2,633,000 | +105.2% | 21,202 | +152.3% | 0.85% | +89.3% |
| Q1 2021 | $1,283,000 | -56.6% | 8,405 | -63.4% | 0.45% | -38.2% |
| Q4 2020 | $2,957,000 | +15.3% | 22,943 | 0.0% | 0.73% | -4.5% |
| Q3 2020 | $2,565,000 | -4.0% | 22,943 | -30.4% | 0.76% | -14.9% |
| Q2 2020 | $2,673,000 | +16.6% | 32,943 | 0.0% | 0.89% | -7.3% |
| Q1 2020 | $2,293,000 | -7.4% | 32,943 | +4.0% | 0.96% | +10.6% |
| Q4 2019 | $2,475,000 | +97.8% | 31,671 | +58.4% | 0.87% | +82.6% |
| Q3 2019 | $1,251,000 | -25.6% | 19,989 | 0.0% | 0.48% | -22.6% |
| Q2 2019 | $1,682,000 | – | 19,989 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
| Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
| Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
| Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
| Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
| Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
| AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
| Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
| STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |